Application Sponsors
Marketing Status
| Discontinued | 001 | 
| Prescription | 002 | 
| Prescription | 003 | 
| Prescription | 004 | 
Application Products
| 001 | INJECTABLE;INJECTION | 500MG/VIAL | 0 | CEFTAZIDIME | CEFTAZIDIME | 
| 002 | INJECTABLE;INJECTION | 1GM/VIAL | 0 | CEFTAZIDIME | CEFTAZIDIME | 
| 003 | INJECTABLE;INJECTION | 2GM/VIAL | 0 | CEFTAZIDIME | CEFTAZIDIME | 
| 004 | INJECTABLE;INJECTION | 6GM/VIAL | 0 | CEFTAZIDIME | CEFTAZIDIME | 
FDA Submissions
|  | ORIG | 1 | AP | 1985-11-20 |  | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 1988-08-04 |  | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 1988-08-26 |  | 
| LABELING; Labeling | SUPPL | 10 | AP | 1992-02-14 |  | 
| LABELING; Labeling | SUPPL | 13 | AP | 1992-02-14 |  | 
| LABELING; Labeling | SUPPL | 14 | AP | 1992-02-14 |  | 
| LABELING; Labeling | SUPPL | 15 | AP | 1992-02-03 |  | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 18 | AP | 1993-10-18 |  | 
| LABELING; Labeling | SUPPL | 19 | AP | 1996-02-26 |  | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 20 | AP | 1996-08-15 |  | 
| LABELING; Labeling | SUPPL | 21 | AP | 1996-07-15 |  | 
| LABELING; Labeling | SUPPL | 24 | AP | 2006-09-08 |  | 
| LABELING; Labeling | SUPPL | 30 | AP | 2009-04-07 |  | 
| LABELING; Labeling | SUPPL | 33 | AP | 2012-03-16 |  | 
| LABELING; Labeling | SUPPL | 34 | AP | 2013-02-11 |  | 
| LABELING; Labeling | SUPPL | 40 | AP | 2020-02-13 | STANDARD | 
| LABELING; Labeling | SUPPL | 42 | AP | 2020-02-13 | STANDARD | 
| LABELING; Labeling | SUPPL | 44 | AP | 2021-07-16 | STANDARD | 
| LABELING; Labeling | SUPPL | 45 | AP | 2021-07-16 | STANDARD | 
Submissions Property Types
| SUPPL | 8 | Null | 0 | 
| SUPPL | 9 | Null | 0 | 
| SUPPL | 18 | Null | 0 | 
| SUPPL | 20 | Null | 0 | 
| SUPPL | 33 | Null | 15 | 
| SUPPL | 34 | Null | 15 | 
| SUPPL | 40 | Null | 15 | 
| SUPPL | 42 | Null | 15 | 
| SUPPL | 44 | Null | 15 | 
| SUPPL | 45 | Null | 15 | 
TE Codes
| 002 | Prescription | AP | 
| 003 | Prescription | AP | 
| 004 | Prescription | AP | 
CDER Filings
ACS DOBFAR
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62640
            [companyName] => ACS DOBFAR
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFTAZIDIME","activeIngredients":"CEFTAZIDIME","strength":"500MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"CEFTAZIDIME","activeIngredients":"CEFTAZIDIME","strength":"1GM\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CEFTAZIDIME","activeIngredients":"CEFTAZIDIME","strength":"2GM\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CEFTAZIDIME","activeIngredients":"CEFTAZIDIME","strength":"6GM\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CEFTAZIDIME","submission":"CEFTAZIDIME","actionType":"500MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"CEFTAZIDIME","submission":"CEFTAZIDIME","actionType":"1GM\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"CEFTAZIDIME","submission":"CEFTAZIDIME","actionType":"2GM\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"CEFTAZIDIME","submission":"CEFTAZIDIME","actionType":"6GM\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )
)